acurate neo | ACURATE neo2™ Aortic Valve System

Keyword	CPC	PCC	Volume	Score	Length of keyword
acurate neo	1.08	0.9	6626	54	11
acurate	1.59	0.9	6136	4	7
neo	0.66	0.5	3074	72	3

Keyword	CPC	PCC	Volume	Score
acurate neo2	0.03	0.7	5883	20
acurate neo	1.97	0.3	6936	39
acurate neo2 valve	0.17	0.5	8601	25
acurate neo valve	1.04	0.8	6996	78
acurate neo 2 mri safety	1.49	0.9	6352	89
acurate neo sizing chart	1.32	0.5	3988	91
acurate neo 2 tavi	0.64	0.8	165	51
acurate neo 2 material	1.5	0.4	9082	28
acurate neo 2 clinical trial	0.42	0.7	3247	87
acurate neo 2 sizing chart	1.48	0.3	7377	1
boston scientific acurate neo 2	0.28	0.8	7764	6
ssed acurate neo	0.65	0.3	3661	86
acurate neo2 aortic valve system	0.5	0.5	4331	46
acurate neo2 boston scientific	0.09	0.4	9488	20
acurate neo2 sizing chart	1.49	0.1	6527	27
acurate neo2 mri safety	0.57	0.6	5936	30
acurate neo2tm	0.58	0.7	9745	12
acurate neo2 mri	1.55	0.1	6933	66
acurate neo2 ifu	1.99	0.6	5373	87
acurate neo2 tf transfemoral ds	1.86	0.8	5894	59
acurate neo2 aortic valve system mrt tauglich	1.75	0.6	5217	3

Search Results related to acurate neo on Search Engine

ACURATE neo2™ Aortic Valve System - Boston Scientific
bostonscientific.com

https://www.bostonscientific.com/en-EU/products/transcatheter-heart-valve/acurateneo2-tavi-valve-system.html

WebIntroducing the ACURATE neo2 Aortic Valve System. Precision today, access tomorrow. Learn more about Boston Scientific’s full TAVI portfolio: iSLEEVE™ Expandable Introducer Set SAFARI²™ Pre-Shaped Guidewire SENTINEL™ Cerebral Protection System. View the full story. Valve Design. *Significant reduction in calcification demonstrated in animal …

DA: 74 PA: 97 MOZ Rank: 77

ACURATE neo2 - Boston Scientific
bostonscientific.com

https://www.bostonscientific.com/en-US/medical-specialties/structural-heart/acurate-ide-trial/acurate-neo2-for-physicians.html

WebThe ACURATE neo2™ Aortic Valve System is the next iteration of the ACURATE neo™ Aortic Valve System. It features Active PVseal™ technology and an extended sealing skirt to cover the full waist of the stent, a radiopaque positioning marker designed to give a clear visual reference for easy and accurate positioning, and extra wide ...

DA: 25 PA: 26 MOZ Rank: 49

ACURATE neo2™ Aortic Valve System - Boston Scientific
bostonscientific.com

https://www.bostonscientific.com/en-EU/medical-specialties/structural-heart/tavi-acurate-neo2.html

WebLearn more about Boston Scientific’s ACURATE neo2 Aortic Valve System – the only supra-annular valve with an open-frame design giving TAVI implanters precision today, and access tomorrow. Discover a treatment for aortic stenosis that has very low rates of PVL, excellent hemodynamic performance and ease of alignment.

DA: 80 PA: 44 MOZ Rank: 97

The ACURATE neo™ and neo2™ Valve Systems - PMC
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524845/

WebJul 16, 2021 · ACURATE neo2 ™ is an evolution of the neo design and was declared CE marked by the manufacturer in 2020. The neo and neo2 valves have been studied in high-risk patients, and the currently active randomized trial for neo2 will include over 1,500 patients of all risk categories in the USA.

DA: 11 PA: 64 MOZ Rank: 39

ACURATE neo: How Is This TAVR Valve Doing to Fit into an …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415021/

WebAug 8, 2020 · Summary. The self-expanding ACURATE neo THV is associated with higher rates of residual aortic regurgitation compared to the balloon-expandable SAPIEN 3 THV. The supra-annular design with low residual gradients may be advantageous in patients with small anatomy and mild degree of calcification.

DA: 49 PA: 89 MOZ Rank: 43

Boston Scientific’s Acurate Neo2 TAVR Device Evaluated for …
citoday.com

https://citoday.com/news/boston-scientifics-acurate-neo2-tavr-device-evaluated-for-hemodynamic-performance-and-clinical-outcomes

WebJun 8, 2022 · The Acurate Neo and Acurate Neo2 aortic valve systems have received CE Mark approval for transcatheter aortic valve replacement (TAVR). In the United States, Acurate Neo2 is an investigational device and restricted under federal law to …

DA: 37 PA: 100 MOZ Rank: 51

The ACURATE neo 2 valve system for transcatheter aortic valve
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639565/

WebJun 20, 2021 · The ACURATE neo2 valve preserves many of the desirable attributes of the prior-generation ACURATE neo valve, and incorporates new features designed to mitigate some of the common complications associated with TAVI. A flexible delivery catheter allows for trackability through tortuous anatomy, radiopaque markers aid reference in …

DA: 47 PA: 99 MOZ Rank: 54

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis
tctmd.com

https://www.tctmd.com/news/scope-i-acurate-neo-comes-short-severe-aortic-stenosis

WebSep 27, 2019 · SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis | tctmd.com. News Conference News. SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis. Noninferiority with Sapien 3 at 30 days was not met, likely due to higher rates of PV leak and acute kidney injury for Acurate Neo. By Marcus A. Banks.

DA: 60 PA: 57 MOZ Rank: 15

ACURATE neo: How Is This TAVR Valve Doing to Fit into an
springer.com

https://link.springer.com/article/10.1007/s11886-020-01364-4

WebAug 8, 2020 · Randomized evidence indicated favorable hemodynamic results with large effective orifice areas and low residual gradients. The self-expanding ACURATE neo THV is associated with higher rates of residual aortic regurgitation compared to the balloon-expandable SAPIEN 3 THV.

DA: 61 PA: 6 MOZ Rank: 13

The ACURATE neo2 valve system for transcatheter aortic valve …
nih.gov

https://pubmed.ncbi.nlm.nih.gov/34148125/

WebDOI: 10.1007/s00392-021-01882-3. Abstract. Background: Transcatheter aortic valve implantation (TAVI) has become standard treatment for elderly patients with symptomatic severe aortic valve stenosis. The ACURATE neo AS study evaluates 30-day and 1-year clinical and hemodynamic outcomes in patients treated with the ACURATE neo2 valve.

DA: 26 PA: 84 MOZ Rank: 81